Cargando…

C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation

BACKGROUND: C14orf166 (chromosome 14 open reading frame 166) plays a crucial role in some tumors, but its role in bladder cancer hasn’t been explored. METHOD: We determined C14orf166 expression in uroepithelial cell, bladder cancer cells, normal bladder tissues and bladder cancer tissues using quant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Mingkun, Ye, Yunlin, Zou, Baojia, Guo, Suping, Zhou, Fangjian, Lu, Keshi, Liu, Jianye, Xu, Zhenzhou, Han, Hui, Liu, Zhuowei, Li, Yonghong, Yao, Kai, Liu, Cundong, Qin, Zike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765182/ https://www.ncbi.nlm.nih.gov/pubmed/26905879 http://dx.doi.org/10.1186/s12967-016-0801-4

Ejemplares similares

An improved ileal conduit surgery for bladder cancer with fewer complications
por: Li, Zhiyong, et al.
Publicado: (2019)

Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2
por: Chen, Mingkun, et al.
Publicado: (2018)

MAP kinase-interacting kinase 1 (MNK1) plays as a tumor suppressor in bladder cancer
por: Chen, Zhuangfei, et al.
Publicado: (2020)

High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancer
por: Tan, Lei, et al.
Publicado: (2020)

C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer
por: Cheang, Tuck-yun, et al.
Publicado: (2016)

Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system
por: Li, Zhiyong, et al.
Publicado: (2021)

CircCA12 Promotes Malignant Process via Sponging miR-1184 and Upregulating RAS Family in Bladder Cancer
por: Jiang, Lijuan, et al.
Publicado: (2021)

Complete transurethral resection of bladder tumor before radical cystectomy is not a risk factor for organ-confined bladder cancer: A case-control study
por: Yuan, Xiaoxu, et al.
Publicado: (2022)

Utility of SAM68 in the progression and prognosis for bladder cancer
por: Zhang, Zhiling, et al.
Publicado: (2015)

Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma
por: Zhou, Yan-Wu, et al.
Publicado: (2017)

C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer
por: Zhang, Weijing, et al.
Publicado: (2015)

Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer
por: Zhou, Yan-Wu, et al.
Publicado: (2018)

RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJ
por: Tang, Huancheng, et al.
Publicado: (2022)

Retraction: Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small cell lung cancer
Publicado: (2019)

Nkx2.8 promotes chemosensitivity in bladder urothelial carcinoma via transcriptional repression of MDR1
por: Zhou, Zhaohui, et al.
Publicado: (2022)

Hub gene associated with prognosis in bladder cancer is a novel therapeutic target
por: Fang, Dengpan, et al.
Publicado: (2023)

High Expression of H3K27me3 Is an Independent Predictor of Worse Outcome in Patients with Urothelial Carcinoma of Bladder Treated with Radical Cystectomy
por: Liu, Jianye, et al.
Publicado: (2013)

An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer
por: Zhou, Ranran, et al.
Publicado: (2022)

Deep Inguinal Lymph Node Metastases Can Predict Pelvic Lymph Node Metastases and Prognosis in Penile Squamous Cell Carcinoma
por: Yang, Zhenyu, et al.
Publicado: (2021)

Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis
por: Chen, Jieping, et al.
Publicado: (2016)

hCLE/C14orf166, a cellular protein required for viral replication, is incorporated into influenza virus particles
por: Rodriguez-Frandsen, Ariel, et al.
Publicado: (2016)

Development of a Ferroptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Bladder Cancer
por: Zhou, Ranran, et al.
Publicado: (2021)

RAB20 Promotes Proliferation via G2/M Phase through the Chk1/cdc25c/cdc2-cyclinB1 Pathway in Penile Squamous Cell Carcinoma
por: Tan, Xingliang, et al.
Publicado: (2022)

Proposal for reclassification of N staging system in penile cancer patients, based on number of positive lymph nodes
por: Li, Zhiyong, et al.
Publicado: (2018)

A circadian rhythm-related gene signature associated with tumor immunity, cisplatin efficacy, and prognosis in bladder cancer
por: Zhou, Ranran, et al.
Publicado: (2021)

A Comparison of Different Prophylactic Intravesical Chemotherapy Regimens for Bladder Cancer Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinomas: A Retrospective 2-center Study
por: Huang, Yong, et al.
Publicado: (2019)

Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4
por: Jia, Changxin, et al.
Publicado: (2023)

Development and validation of an intra-tumor heterogeneity-related signature to predict prognosis of bladder cancer: a study based on single-cell RNA-seq
por: Zhou, Ranran, et al.
Publicado: (2021)

Concurrent Bladder Lymphoma and Bladder Cancer Presenting as Metastatic Bladder Cancer
por: Kim, Jae Heon, et al.
Publicado: (2012)

Phosphorylated MAPK14 Promotes the Proliferation and Migration of Bladder Cancer Cells by Maintaining RUNX2 Protein Abundance
por: Liu, Junlong, et al.
Publicado: (2020)

Activating transcription factor 5 (ATF5) promotes tumorigenic capability and activates the Wnt/b-catenin pathway in bladder cancer
por: Zhou, Junhao, et al.
Publicado: (2021)

The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients
por: Guo, Shengjie, et al.
Publicado: (2017)

CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration
por: Gong, Yanqing, et al.
Publicado: (2015)

Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer
por: Chen, Dong, et al.
Publicado: (2021)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups
por: Tian, Zijian, et al.
Publicado: (2020)

ADNP Upregulation Promotes Bladder Cancer Cell Proliferation via the AKT Pathway
por: Zhu, Shuai, et al.
Publicado: (2020)

Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer
por: Zhang, Qi, et al.
Publicado: (2022)

Induction of Paclitaxel Resistance by ERα Mediated Prohibitin Mitochondrial-Nuclear Shuttling
por: Dong, Pei, et al.
Publicado: (2013)

AB103. Overexpression of RNF2 is an independent predictor of outcome in patients with urothelial carcinoma of the bladder underwent radical cystectomy
por: Liu, Zhuowei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_roqsrb9hcf1vt74dq9bkp0vbfg